C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 30.46 CNY -0.13% Market Closed
Market Cap: ¥23B

China National Medicines Corp Ltd
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

China National Medicines Corp Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Goodwill
¥203.8m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
59%
Sinopharm Group Co Ltd
HKEX:1099
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Goodwill
¥12.7B
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
10%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Goodwill
¥806m
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
26%
Huadong Medicine Co Ltd
SZSE:000963
Goodwill
¥2.9B
CAGR 3-Years
6%
CAGR 5-Years
15%
CAGR 10-Years
71%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Goodwill
¥1.9B
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
37%
No Stocks Found

China National Medicines Corp Ltd
Glance View

Market Cap
23B CNY
Industry
Health Care

China National Medicines Corp Ltd., often known as Sinopharm Group's public face, is a leviathan in the realm of pharmaceutical distribution. Headquartered in Beijing, this company is deeply entrenched in the layers of China's healthcare system. Its operations are woven through a vast network that includes the wholesale and retail distribution of an extensive range of pharmaceutical products. The company prides itself on streamlining the supply chain, connecting pharmaceutical manufacturers directly with hospitals, clinics, and pharmacies. By leveraging its logistical expertise and expansive reach, Sinopharm ensures that essential medicines flow seamlessly from producers to end-users, maintaining the vital heartbeat of the healthcare industry across China. In addition to its core distribution business, China National Medicines Corp Ltd. delves into the realm of medical device distribution and other healthcare-related services, diversifying its revenue streams. A significant portion of its income comes from partnerships and agreements with international pharmaceutical behemoths, allowing it to import and distribute advanced medicines and technology within China. By capitalizing on these strategic alliances, the company not only bolsters its portfolio but also strengthens its market position. This symbiotic relationship with both domestic and global players underpins its financial performance, making China National Medicines not just a distributor but a pivotal gatekeeper in the evolving landscape of China's healthcare industry.

Intrinsic Value
41.59 CNY
Undervaluation 27%
Intrinsic Value
Price
C

See Also

What is China National Medicines Corp Ltd's Goodwill?
Goodwill
203.8m CNY

Based on the financial report for Sep 30, 2025, China National Medicines Corp Ltd's Goodwill amounts to 203.8m CNY.

What is China National Medicines Corp Ltd's Goodwill growth rate?
Goodwill CAGR 10Y
59%

Over the last year, the Goodwill growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett